ADRB3 and necrotizing enterocolitis: Although caution is mandatory when trying to extrapolate the results from animal studies to humans, our finding that a β3-AR agonist preserved the integrity of the gut surface epithelium could have significant clinical implications, particularly in the prevention of necrotizing enterocolitis (NEC), in which an impaired intestinal barrier predisposes patients to bacterial leakage [52].